OptiChroniX GmbH

Software as Medical Device - AI driven digital advisors

OptiChroniX is a Swiss Digital Therapeutics company dedicated to improving brain health early.

We strive to optimize lifestyle and make medicine smart, so as to improve clinical outcomes, quality of life, cost-effectiveness and budget impact of clinical treatment.

At OptiChroniX, we develop digital health interventions at the intersection of biomedical, behavioural, computing and engineering research, deployed on smartphones to personalize and track a patients health progress by collecting data from other wearables and nearables.

The informed choices offered aim to provide tailored coaching in order to improve health literacy and medication adherence, and to positively impact modifiable risk factors primarily responsible for the cognitive decline in patients affected by dementia

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Milestone

09.02.2020

InnoCheck

Deal

15.03.2019

Strategic Partnership Sprout Behavioral Science

No Jobs

Videos

Imagine People Affected with Dementia

https://vimeo.com/693932351/a2e682f4ba
>>Venture>>

The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.

Website

OptiChroniX GmbH

Software as Medical Device - AI driven digital advisors

Headquarter:
Schoenenbuch

Foundation Date:
May 2020

Technology:

  • ICT

Sectors:

  • Bioinformatics
  • Big Data
  • Cardiovascular
  • Digital Health
  • Diagnostics
  • Healthcare infrastructure
  • IoT
  • Machine Learning / AI
  • Medical devices
  • Mobile
  • Medtech
  • Neurology
  • Patient monitoring

Support received

  • Support venturekick